NEOADJUVANT IMMUNOTHERAPY
Clinical trials for NEOADJUVANT IMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop liver cancer from coming back after surgery
Disease control Not yet recruitingThis study tests whether giving a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) before surgery can help prevent liver cancer from returning in people with early-stage but high-risk disease. About 30 adults with resectable stage IB or IIA hepatocellular car…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 09:56 UTC
-
Chemo-Free Pre-Op combo shows promise for lung cancer
Disease control Not yet recruitingThis study tests a new approach for people with operable non-small cell lung cancer that does not have certain gene changes. Instead of chemotherapy, participants will receive a short course of focused radiation (SBRT) plus two drugs: an immunotherapy (tislelizumab) and an antian…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Can less lung surgery after immunotherapy be just as safe?
Disease control Not yet recruitingThis study looks at people with stage II to IIIB non-small cell lung cancer whose tumors shrank after immunotherapy. It compares two surgery approaches: removing only the shrunken tumor area versus removing the original larger area. The goal is to see if less surgery can preserve…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Immunotherapy before surgery may stop merkel cell cancer spread
Disease control Not yet recruitingThis study tests whether giving the immunotherapy drug cemiplimab before standard surgery can prevent Merkel cell skin cancer from spreading to nearby lymph nodes. About 135 adults with early-stage cancer (stage I or II) will receive either cemiplimab or a placebo before their ly…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 20, 2026 11:55 UTC